Literature DB >> 8655701

Lipid screening in an elderly population: difficulty in interpretation and in detection of occult metabolic disease.

A F Winder1, C Jagger, D P Garrick, D T Vallance, P F Butowski, J Anderson, M Clarke.   

Abstract

AIMS: To determine lipid profiles and associations with other metabolic disease in a representative British elderly population.
METHODS: Part of a prevalence survey of dementia in all 75+ year olds conducted from the large general practice serving the town and surrounding area of Melton Mowbray, Leicestershire (the M-old study). Patients (n = 224) aged from 75 to 98 years, and representative of the overall population, also provided pre-prandial blood samples on which various age and nutrition related analytes were determined. These included documented medical history, thyroid stimulating hormone (TSH), glucose, immunoglobulins, and lipid profile in plasma.
RESULTS: Cholesterol and lipid variables showed wide scatter, with some negative trends but no significant associations with age for total cholesterol, high density lipoprotein (HDL) cholesterol, the ratio of total to HDL cholesterol or triglycerides. Women had significantly higher concentrations of total and HDL cholesterol at all ages. Serum TSH was above 6.0 mU/1 in 10/205 patients, random glucose was above 11.2 mmol/l in nine of 207 patients, borderline dysglobulinaemia was present in four of 210 patients, all without correlation with cholesterol concentrations.
CONCLUSION: This British data is consistent with an inverse correlation between survival and cholesterol, but wide scatter restricts reliance on single result lipid data in individual patient management. Random lipid screening is also unhelpful, inefficient and without added value in revealing other age related and unrecognised occult metabolic disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8655701      PMCID: PMC500446          DOI: 10.1136/jcp.49.4.278

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  39 in total

1.  Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance.

Authors:  C J Glueck; R I Levy; H I Glueck; H R Gralnick; H Greten; D S Fredrickson
Journal:  Am J Med       Date:  1969-08       Impact factor: 4.965

Review 2.  Lipoprotein metabolism in diabetes mellitus.

Authors:  B V Howard
Journal:  J Lipid Res       Date:  1987-06       Impact factor: 5.922

3.  Evidence-based management of dyslipidaemia.

Authors:  R Jackson; R Beaglehole
Journal:  Lancet       Date:  1995-12-02       Impact factor: 79.321

4.  Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy.

Authors:  M Aviram; R Luboshitzky; J G Brook
Journal:  Clin Biochem       Date:  1982-02       Impact factor: 3.281

5.  Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure.

Authors:  W M Tunbridge; D C Evered; R Hall; D Appleton; M Brewis; F Clark; J G Evans; E Young; T Bird; P A Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1977-12       Impact factor: 3.478

6.  Determinants of 10-year survival after primary myocardial revascularization.

Authors:  D M Cosgrove; F D Loop; B W Lytle; C C Gill; L A Golding; C Gibson; R W Stewart; P C Taylor; M Goormastic
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

7.  CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

Authors:  M Roth; E Tym; C Q Mountjoy; F A Huppert; H Hendrie; S Verma; R Goddard
Journal:  Br J Psychiatry       Date:  1986-12       Impact factor: 9.319

8.  Thyroid dysfunction and hypercholesterolaemia in the general population of Glasgow, Scotland.

Authors:  J J Series; E M Biggart; D S O'Reilly; C J Packard; J Shepherd
Journal:  Clin Chim Acta       Date:  1988-03-15       Impact factor: 3.786

9.  Population-based study of glycosylated hemoglobin, lipids, and lipoproteins in nondiabetic adults.

Authors:  E Barrett-Connor; M H Criqui; J L Witztum; T Philippi; A Zettner
Journal:  Arteriosclerosis       Date:  1987 Jan-Feb

10.  Cholesterol and mortality. 30 years of follow-up from the Framingham study.

Authors:  K M Anderson; W P Castelli; D Levy
Journal:  JAMA       Date:  1987-04-24       Impact factor: 56.272

View more
  2 in total

Review 1.  Management of lipids in the elderly.

Authors:  A Winder
Journal:  J R Soc Med       Date:  1998-04       Impact factor: 5.344

Review 2.  ACP Broad Sheet no 151: September 1997. Investigation of dyslipidaemias.

Authors:  A F Winder; W Richmond; D T Vallance
Journal:  J Clin Pathol       Date:  1997-09       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.